Institutional investors hold a majority ownership of ZTS through the 95.82% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2017, these large investors purchased a net $4.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PENNSYLVANIA TRUST CO. Bought 637.1 Thousand shares of Zoetis Inc